Nr 508 final exam - Study guides, Class notes & Summaries

NR 508 Pharmacology Final Exam (Latest 2024 / 2025) Questions and Answers (Verified Answers)

NR 508 Final Exam 2024 Questions and Answers (Graded A)NR 508 Final Exam 2024 Questions and Answers (Graded A)NR 508 Final Exam 2024 Questions and Answers (Graded A)NR 508 Final Exam 2024 Questions and Answers (Graded A) Know Initial treatment choices for HTN - ANSWER-Diuretics, beta blockers, calcium channel blockers, ace inhibitors and angiotensin II (ARB's) Know first line treatment options for HTN for African Americans without renal impairment. - ANSWER-Calcium Channel Blockers with a t...

NR 508 Final Exam study guide (1) 2020 Cardiovascular management: Know Initial treatment choices for HTN Ace inhibitors and ARBs Know first line treatment options for HTN for African Americans without renal impairment. Thiazides First line option for HTN for anyone with chronic kidney disease ACEIs or ARBs, appropriate diuretic therapy, and dietary salt restriction make up the foundation for the treatment of HTN in CKD. Lisinapril and Furosomide. IN most instances, the hypertensive CKD patient r...

NR 508 Final Exam Practice Questions and Answers with Rationale (Verified Solutions) (Latest Update)

Nr 508 final examination Nr 508 final examination NR 508 Final Exam A patient who has diabetes reports intense discomfort when needing to void.A urinalysis is normal. To treat this, the primary care NP should consider prescribing: flavoxate (Urispas). bethanechol (Urecholine). phenazopyridine (Pyridium). This patient is describing urge incontinence, or overactive bladder, which occurs when the detrusor muscle is hyperactive, causing an intense urge to void before the bladder is full. U...

The decision may be made to switch from twice daily neutral protamine Hagedorn (NPH) insulin to insulin glargine to improve glycemia control throughout the day. If this is done: 1. The initial dose of glargine is reduced by 20% to avoid hypoglycemia. 2. The initial dose of glargine is 2 to 10 units per day. 3. Patients who have been on high doses of NPH will need tests for insulin antibodies. 4. Obese patients may require more than 100 units per day. - ANSWER-1. The initial dose of glargine ...

NR 508 Final Exam updated Question 1 2 / 2 pts A patient who has diabetes reports intense discomfort when needing to void. A urinalysis is normal. To treat this, the primary care NP should consider prescribing: flavoxate (Urispas). bethanechol (Urecholine). phenazopyridine (Pyridium). Correct! oxybutynin chloride (Ditropan XL). This patient is describing urge incontinence, or overactive bladder, which occurs when the detrusor muscle is hyp...

NR 508 Final Exam Graded A (NEWEST) NR 508 Final Exam Graded A (NEWEST) NR 508 Final Exam Graded A (NEWEST)

NR 508 Final Exam 2 (Latest 2024 / 2025) Questions and Answers (Verified Answers)

NR 508 Final Exam Questions With 100% Correct Answers Latest Update 2024 (Graded A+) A patient who has diabetes reports intense discomfort when needing to void. A urinalysis is normal. To treat this, the primary care NP should consider prescribing: oxybutynin chloride (Ditropan XL). This patient is describing urge incontinence, or overactive bladder, which occurs when the detrusor muscle is hyperactive, causing an intense urge to void before the bladder is full. Urge incontinence is associa...